Alkermes plc (ALKS)
Company Info
Highlights
$5.24B
$2.10
14.95
-1,057.29
$1.51B
$1.33B
$447.71M
$22.90 - $36.45
$39.57
10.87%
6.79
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Alkermes plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Alkermes plc (ALKS) returned 5.63% year-to-date (YTD) and 23.55% over the past 12 months. Over the past 10 years, ALKS returned -6.48% annually, underperforming the S&P 500 benchmark at 10.31%.
ALKS
5.63%
3.02%
3.72%
23.55%
15.24%
-6.48%
^GSPC (Benchmark)
-4.26%
11.24%
-5.02%
8.55%
14.02%
10.31%
Monthly Returns
The table below presents the monthly returns of ALKS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 9.63% | 8.88% | -3.82% | -12.87% | 5.60% | 5.63% | |||||||
| 2024 | -2.49% | 9.76% | -8.82% | -9.35% | -4.65% | 2.99% | 13.36% | 4.14% | -1.62% | -8.18% | 12.92% | -0.90% | 3.68% |
| 2023 | 9.61% | -6.63% | 5.42% | 1.28% | 1.33% | 8.19% | -6.45% | -0.31% | -4.04% | -13.64% | -0.21% | 14.91% | 6.16% |
| 2022 | 9.63% | -2.51% | 5.83% | 9.65% | 3.47% | -0.20% | -14.07% | -7.54% | -5.66% | 1.66% | 9.16% | 5.45% | 12.34% |
| 2021 | 5.21% | -9.29% | -1.89% | 17.83% | 3.00% | 8.16% | 5.51% | 20.83% | -1.34% | -1.78% | -27.63% | 6.11% | 16.59% |
| 2020 | -14.66% | 19.70% | -30.81% | -4.92% | 19.33% | 18.64% | -7.21% | -8.16% | 0.18% | -1.93% | 12.37% | 9.26% | -2.21% |
| 2019 | 11.39% | 1.22% | 9.68% | -16.91% | -28.96% | 4.64% | 2.75% | -9.41% | -7.01% | 0.10% | 7.63% | -2.95% | -30.87% |
| 2018 | 4.46% | -0.16% | 1.54% | -23.62% | 6.62% | -12.80% | 6.54% | 2.26% | -5.35% | -3.79% | -10.75% | -19.02% | -46.08% |
| 2017 | -2.64% | 4.42% | 3.54% | -0.43% | -0.84% | 0.36% | -6.14% | -6.67% | 0.12% | -4.09% | 7.24% | 4.67% | -1.53% |
| 2016 | -59.67% | 0.81% | 5.95% | 16.26% | 16.75% | -6.87% | 15.46% | -12.28% | 7.45% | 7.19% | 12.74% | -2.20% | -29.98% |
| 2015 | 23.38% | -2.77% | -13.21% | -9.18% | 10.35% | 5.30% | 8.83% | -14.94% | -1.49% | 22.58% | 2.00% | 8.21% | 35.55% |
| 2014 | 19.72% | -0.02% | -9.41% | 4.92% | -0.97% | 9.87% | -15.04% | 4.61% | -4.16% | 17.91% | 8.84% | 6.43% | 44.02% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ALKS is 74, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Alkermes plc (ALKS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Alkermes plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Alkermes plc was 96.15%, occurring on Jul 11, 2002. The portfolio has not yet recovered.
The current Alkermes plc drawdown is 69.02%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.15% | Mar 2, 2000 | 591 | Jul 11, 2002 | — | — | — |
| -92.95% | Jan 10, 1992 | 755 | Jan 4, 1995 | 537 | Feb 18, 1997 | 1292 |
| -64.98% | Feb 19, 1997 | 48 | Apr 28, 1997 | 440 | Jan 26, 1999 | 488 |
| -44.58% | Nov 4, 1991 | 18 | Nov 27, 1991 | 24 | Jan 3, 1992 | 42 |
| -28.52% | Mar 22, 1999 | 42 | May 19, 1999 | 57 | Aug 10, 1999 | 99 |
Volatility
Volatility Chart
The current Alkermes plc volatility is 13.87%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Alkermes plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Alkermes plc, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 18.9% positive surprise.
Valuation
The Valuation section provides an overview of how Alkermes plc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ALKS, comparing it with other companies in the Biotechnology industry. Currently, ALKS has a P/E ratio of 15.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ALKS compared to other companies in the Biotechnology industry. ALKS currently has a PEG ratio of -1,057.3. This PEG ratio is negative, which typically signals that the company's earnings are expected to decline. A negative PEG is not considered meaningful for valuation purposes.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ALKS relative to other companies in the Biotechnology industry. Currently, ALKS has a P/S ratio of 3.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ALKS in comparison with other companies in the Biotechnology industry. Currently, ALKS has a P/B value of 3.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |